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Background: In Catalonia, a law was passed in 2010 to incorporate HIV infection as a mandatory disease and to
reduce under-reporting, perform follow-up and to improve prevention. Currently, there are studies that describe the
surveillance of new diagnoses of HIV infection. However, there are no studies that compare the change from
voluntary to mandatory notification. This study evaluates the impact of mandatory notification on the registered
cases of newly diagnosed HIV infections in a city with a concentrated epidemic.
Methods: We analysed newly diagnosed HIV infections that were included in the city register. A descriptive analysis
compared the number and the epidemiological characteristics of cases that were declared in two different periods
(when notification was voluntary in 2001–2009 and when mandatory in 2010–2011). Time series analysis was
conducted, evaluating trends and changes by fitting a Poisson regression model. The Epidemiology Service from
the Public Health Agency was responsible for gathering and analyzing data and producing reports on
communicable disease for the city. The data used in this study is openly available.
Results: Overall, 4510 cases of HIV infection were registered, 81.9% were men and 74.5% of them aged over 30.
Among men, 55.6% were men who had sex with men (MSM), and among women, the most common route of
transmission was heterosexual (HTS) with 65.4%. An annual average of 560 cases was registered between 2010
and 2011. This represents an increase of 33% from the annual average over the previous period (p<0.001). Time
series analysis showed that the probability of notification was 2.8 (95% confidence interval 2.4-3.3) times higher
with mandatory notification than in the earlier period. There was a statistically significant decrease of missing
values in the period of mandatory notification (p<0.001).
Conclusions: Mandatory notification of HIV has resulted in an increase in detection of newly diagnosed infections,
reduced the levels of missing data and has provided a more realistic picture of the epidemiology of HIV. This
information also helps to improve the suitability of interventions aimed at HIV prevention and control.
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With the introduction of highly active antiretroviral treat-
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distribution, and reproduction in any mediumHIV infection [1]. A change occurred in the natural course
of the infection, prolonging the period between infection
and development of AIDS, as well as an important reduc-
tion in mortality [1]. As a consequence, data from AIDS
registries no longer reflected the magnitude nor the char-
acteristics of the epidemic [1,2]. Since 1999, the World
Health Organisation (WHO) has promoted the implemen-
tation of population-based surveillance systems, for the
new HIV cases in developed countries [3]. Since the notifi-
cation is used in only some areas, this does not allowentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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the infection [4].
Despite being one of the most affected Western
European countries in terms of HIV infection rates, Spain
does not have state-wide population-level data on HIV
infection [2,5,6]. Epidemiological surveillance has been
carried out voluntarily, based on the notification of new
diagnoses of HIV infection by the various Autonomous
Communities [7] and among them, Catalonia, which
began notification of new cases in January 2001. It should
be taken into account that levels of under-reporting could
be around 15 to 30% [8]. Moreover, voluntary notification
systems cannot ensure the elimination of duplicates and
there is no follow-up until the development of AIDS or
death. In 2010, Catalonia passed a law which incorporates
HIV infection as an individually name-based mandatory
disease [9] with the aim of reducing under-reporting,
performing follow-up and improving prevention in the
same way that AIDS had been since 1987 [10,11].
A total of 28 of the 30 countries belonging to the
European Union were notifying new cases of HIV in 2009.
In 2000, 13 of these countries had national notification
systems and in 8 of them, notifications were mandatory
[12,13]. Despite the existence of these reporting systems,
there are no studies published evaluating the impact of the
change from voluntary to mandatory notification.
The objective of this study was to evaluate the impact of
mandatory notification on the numbers of new diagnoses
of HIV infections reported in a large city with a concen-
trated epidemic; comparing the epidemiological character-
istics of those cases registered before to those registered
after the mandatory notification came into effect.
Methods
Study design and study population
The city of Barcelona is situated in the northeast of
Spain. It had a population of 1,619,337 inhabitants in
2010 [14]. AIDS rates were 46.7 per 100,000 inhabitants
in 1994, before the introduction of HAART, and 4.5 per
100,000 inhabitants in 2010 [10,11]. This city has a low-
level of concentrated epidemic (where high levels of in-
fection are found only in specific groups) and estimates
that HIV prevalence is mainly based on data collected
from populations most at risk – especially men who
have sex with men (MSM) [3].
We analysed registered cases of new diagnoses of HIV
infection in Barcelona over the period from 1 January
2001 to 31 December 2011, excluding AIDS diagnoses.
A structured questionnaire was used to collect clinical
and epidemiological information: sex, age, region of birth,
route of transmission, CD4 cell count and reporting
centre. Doctors reported new diagnoses of HIV. The
Epidemiology Service from the city’s Public Health Agency
was responsible for gathering and analyzing data andproducing reports on communicable disease for the city,
therefore the data used in this study is openly available.
Other changes, such as testing policy, campaigning to pro-
mote HIV testing or change of case definition, were not
accompanied in the switch from voluntary to mandatory
notification.
Statistical methods
A descriptive analysis was carried out, comparing the
number and epidemiological characteristics of cases regis-
tered voluntarily from 2001 to 2009, with those corre-
sponding to the period of mandatory notification from
2010 to 2011, by means of the chi-squared test. A Poisson
regression model was fitted to analyse the time series.
Quarter was considered as a unit of time, taking the first
period as reference. In order to test trend, a linear compo-
nent was fitted, adding a quadratic function that allows for
attenuation of trend over time. A dummy variable indicat-
ing the mandatory period was then included, in order to
evaluate the magnitude of the effect of the law coming
into force on the number of newly notified diagnoses.
Finally, an interaction term was included to allow a change
in the incidence trend in the second period. The analysis
was conducted on the total number of cases, as well as
stratified by demographic variables, transmission route
and reporting centre. Furthermore, interactions between
quarter and the stratifying variables were tested. The likeli-
hood test was used to compare models, and only statisti-
cally significant results were included in the final models.
95% confidence intervals (CI) and p-values < 0.05 were
considered statistically significant. All analyses were car-
ried out with SPSS version 18 [15] and STATA version
11.0 [16].
Results
During the study period, 4510 new diagnoses of HIV
infection were notified, representing an average of 410
cases annually. The epidemiological characteristics of new
diagnoses reported are showed in Table 1. 81.9% were
men, and 74.5% were aged over 30 years. By sex, only 43%
of the men and 32.5% of the women were born in Spain.
Among men, 45.5% were MSM, 10.8% were heterosexuals
(HTS), and 9.3% were intravenous drug users (IDU).
Among women, the most common route of transmission
was HTS (65.4%), followed by IDU (15.2%). At the time of
their diagnosis, 39.3% had CD4>350 cell/ul, 14.7% be-
tween 350 and 200 cell/ul, 12.9% under 200 cell/ul and
33.3% unknown. The most common reporting centre was
a hospital, accounting for 64.6% of all reported cases.
The annual average of notifications over the period
2001–2009 was 376.6, while that for 2010–2011 was
560, representing a 33% increase in the annual number
of notifications (p <0.001). The epidemiological charac-
teristics of the cases by period are showed in Table 1. It
Table 1 Epidemiological characteristics of HIV new diagnoses reported in Barcelona (2001 – 2011)
2001-2011 2001-2009 Voluntary period 2010-2011 Mandatory period P-value*
n=(4510) n=(3390) n=(1120)
N % N % N %
Sex Men 3692 81,9 2713 80.0 979 87.4 <0.001
Women 818 18,1 677 20 141 12.6
Age (<30 and >30 years age) <30 years of age 619 13,7 289 8,5 330 29.5 <0.001
>30 years of age 3358 74,5 2574 76 784 70
Unknown 533 11,8 527 15.5 6 0.5
Age groups 14-19 years of age 9 0,2 0 0 9 0.8 <0.001
20 -29 years of age 474 10,5 207 6.1 267 23.8
30-39 years of age 1562 34,6 1117 32.9 445 39.7
40-49 years of age 1306 29,0 1021 30.1 285 25.4
50-59 years of age 418 9,3 343 10.1 75 6.7
> 60 years of age 208 4,6 175 5.2 33 2.9
Unknown 533 11,8 527 15.5 6 0.5
Region of birth Spain 1854 41,1 1304 38.5 550 49.1 <0.001
Western Europe and North America 281 6,2 174 5.1 107 9.6
Latin America and Caribbean 849 18,8 561 16.5 288 25.7
Eastern Europe and Central Asia 145 3,2 86 2.5 59 5.3
North Africa and Middle East 54 1,2 37 1.1 17 1.5
Sub-Saharan Africa 198 4,4 148 4.4 50 4.5
Unknown 1129 25,0 1080 31.9 49 4.4
Route of transmission HTS men 487 10,8 359 10.59 128 11.43 <0.001
HTS women 536 11,9 429 12.65 107 9.55
MSM 2052 45,5 1387 40.91 665 59.38
IDU men 419 9,3 334 9.85 85 7.59
IDU women 124 2,7 103 3.04 21 1.88
Unknown 892 19,8 778 23,0 114 10.18
CD4 count > 350 cell/ul 1773 39,3 1257 37.1 516 46.1 <0.001




















Table 1 Epidemiological characteristics of HIV new diagnoses reported in Barcelona (2001 – 2011) (Continued)
<200 cells/ul 580 12,9 436 12.9 144 12.9
Unknown 1492 33,1 1228 36.2 264 23.6
Reporting centre Hospital 2915 64,6 2060 60.8 855 76.3 <0.001
Primary care 1595 35,4 1330 39.2 265 23.7
Comparison between voluntary notification period with mandatory notification period. (2001–2009 versus 2010–2011).
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Figure 1 Evolution of new HIV diagnoses notified in Barcelona,
between January 2001 and December 2011.
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composition by sex, with an increase in the proportion of
notifications corresponding to men. The majority of cases
were aged over 30 years. However, a change was seen in the
proportion of notifications among individuals aged under
30, which rose from 8.1% to 29.5% (p<0.001). With regard
to region of birth, those born in Spain presented a decline
in notifications, which led to an increase in the relative pro-
portions of foreign-born individuals, the most common of
which were people born in Latin American and Caribbean
countries. The rate of notification corresponding to cases of
sexual transmission rose from 64.2% to 80.4% (p<0.001),
particularly among MSM whereas among IDU, there was a
decline from 12.9 to 9.5%. There was a significant decline
in the proportion of missing values for most of the vari-
ables during the period of mandatory notification, espe-
cially region of birth and route of transmission, comparing
with the voluntary period (p<0.001).
As shown in Table 2, the probability of notification in-
creased by 2.8 times (CI 2.4-3.3) with the introduction
of mandatory HIV notification, compared to the period
when notification was voluntary. Figure 1 shows a rise in
the number of cases of HIV notified up to the year 2006,
a year in which a change in the trend may be seen, after
which cases began to decline. With the introduction of
mandatory notification, an increase is observed in the
level of cases notified. However, the decreasing trend of
series of quarters is not altered by the change in notifica-
tion, since the interaction between the trend and the law
coming into force was not significant.
Figure 2 illustrates the increase in HIV notified cases,
following the introduction of the law, in terms of sex,
age, region of birth, route of transmission and reporting
centre. Only the interaction between sex and quarter
was statistically significant (p <0.001), suggesting that
the trend differs between men and women and that, in
men, the decrease in HIV reporting was greater than in
women in the period of voluntary notification.
Discussion
In Barcelona, AIDS has been a mandatory notified disease
since 1986, and HIV was included in the registry as a
voluntary notifiable disease only until 1996 [8]. During the
HIV/AIDS epidemic there was, and continues to be, con-
troversy over whether HIV infection should be notified.Table 2 Effect of the introduction of mandatory notification o
Linear Trend
Quadracticadjustmentterm
Indicator of introduction of mandatory notification
Poisson Regression N cases= α+β1(Quarter from origen) + β2(Quarter from origen)
2
RR: relative risk, CI: confidence interval.
* Poisson Regression.Following a long debate over many years, in 2010 Catalonia
passed a law making a mandatory registry of HIV infection
[8]. Such a mandatory registry permits better characterisa-
tion of the infection, avoidance of duplication, the study of
sexual partners, effectiveness of therapy, and follow-up of
cases of infection until the appearance of AIDS, or death
[17]. However, some studies have suggested that the intro-
duction of this type of notification could diminish the
number of persons who undergo the test; however these
predictions have not been reflected in significant declines
in testing in the United States [18].
In our study, both the results of bivariate analysis and
of time series analysis showed that the introduction of
mandatory notification of new diagnosis of reported
HIV infection led to an increase in such notification of
almost three times. This increase in the completeness of
notification results in a more precise description of the
epidemiological situation regarding HIV infection. The
epidemiological characteristics are similar in both pe-
riods, although some proportions have changed, new
diagnoses being more common among men with higher
risk of sexual transmission; particularly MSM and those
aged over 30 years. There is a notable percentage in-
crease of groups at risk following the introduction of the
law, such as individuals aged under 30 and people born
outside Spain. Regarding the notifying centre, hospitals
are the main sources of notifications in both periods.f new HIV diagnoses in Barcelona




+ β3(mandatory notification indicator).
aFigure 2 Reporting of new HIV diagnoses by quarter. Stratified by sex (a), route of transmission (b), age (c), region of birth (d), and reporting
center (e). Barcelona, January 2001 – December 2011.
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data available at national level (2003–2010) revealed differ-
ences with respect to the proportions in the different
categories of transmission. It is important to stress that
national-level data cover 71% of the population
(32,843,416 inhabitants in 2010) [19], making it difficult to
extrapolate to the rest of the country, since the degree and
patterns of HIV transmission differ between the different
Autonomous Communities. It should also be noted that
amongst them, the notification of new cases of HIV is vol-
untary and that some proportion of these cases have prob-
ably not been notified [19]. This reveals the need to have a
notification system that permits more exhaustive surveil-
lance of the epidemic, in order to obtain appropriate qual-
ity and quantity of information. Thus, this information
will allow the estimation of the magnitude of the infection
and to monitor its trends [20], especially in the large cities,
which is where cases tend to be concentrated. Comparing
with the data of HIV diagnoses that were reported by the
EU/EEA countries in 2011 (rate of 5.7 per 100000 in the
population), 10% of all HIV diagnoses were reportedamong young people aged 15 to 24 years, and 30% among
MSM [21]. These trends are similar to those observed in
Barcelona, describing a concentrated epidemic especially
by sexually transmitted infection, mainly in MSM.
Studies with regard to the switch from voluntary to
mandatory notification were not possible to find. However,
in other settings, it has been observed that appropriate
and exhaustive systems of surveillance of transmissible in-
fections, not only HIV, generate more precise information
at population level, presenting a more realistic picture of
the infection situation [22,23]. Accurate information has
helped large scale efforts in eradicating smallpox [24] and
reducing dracunculiasis in Asia and Africa [25,26].
Reporting of HIV infection must be interpreted with
caution however, taking into account other available epi-
demiological data, because these reports do not provide
a direct measurement of the incidence or prevalence of
HIV infection [12,13]. The proportion of HIV infected
individuals, who are diagnosed and reported, varies
according to the phase of the epidemic [27], HIV testing
patterns [28], and characteristics of surveillance systems.
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a registry, varies despite of their mandatory or voluntary
state. But with a mandatory notification registry, all
cases that have been diagnosed are reported, despite
their infection state. HIV mandatory reporting is helping
to improve assessment of the scale and extent of recent
HIV transmission in the population [12], to visualize a
better picture of HIV endemic situation in the city and
to describe the epidemiological characteristics of emer-
ging risk groups. It is important to stress that with
mandatory notification, elimination of duplicate reports
and the ability to match reports of HIV infection with
other data sets are accomplished [12]. These are two
characteristics [3], which are essential requirements, for
an effective HIV reporting system. Another important
advantage of mandatory notification is that it is possible
to recover data by active surveillance; therefore there
might be a decrease in missing data as it was observed
in our analysis.
Strengths and limitations
Time series analysis has permitted the description and
estimation of the evolution in trends affecting the notifi-
cation of new diagnoses of HIV infection [29,30]. Thus,
while on the one hand we observe an increase in the
number of mandatory notifications, the slope of the
overall trend persists in both periods.
Among the limitations of this study, one is the short
period of follow-up of mandatory notification. This raises
the issue of the need to continue its evaluation, in order to
determine whether the changes and the rise in number of
notifications persist over time.
Another aspect to be taken into account is that the
analysis was conducted with the start date of mandatory
notification as January 2010, despite the fact that the law
only came into force in July 2010, and the publication of
the 2010 manual of notifiable diseases and mandatory
notification of HIV infection was also included [31].
Consequently, some centres, not notified when this was
voluntary, began to do so at the beginning of 2010. We
decided that the first two quarters of 2010 were included
in the analysis, as the impact of mandatory notification
starts from the second quarter of this year, despite the
law only coming into force in July 2010.
Conclusions
In conclusion, while the voluntary system of notification
was useful in order to describe global trends of the in-
fection, HIV mandatory notification increased the num-
ber of new diagnoses notified, made visible a change in
the relative proportions of epidemiological characteris-
tics of the HIV infection, such as greater representation
of men (particularly the MSM group), has led to the ap-
pearance of certain groups that were formerly not sostrongly represented, such as individuals aged under 30
years. This information, more exhaustive and of a higher
quality than that obtained with the voluntary notification
system, will serve to improve evaluation and design of
prevention programmes allowing more effective control
of HIV infection.
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